CoChat
Sign Up
Cited by 38

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies

Zeng, Hongxiang, He, Hailan, Guo, Lei, Li, Jia, Lee, Minjung, Han, Wei, Guzman, Anna G., Zang, Shengbing, Zhou, Yubin, Zhang, Xiaotian, Goodell, Margaret A., King, Katherine Y., Sun, Deqiang, Huang, Yun·2019·Cancer Letters
DOI 10.1016/j.canlet.2019.09.013PMC PMC6945766
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.canlet.2019.09.013

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 24

  1. Lemonnier, 2012, Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters, Blood, 120, 1466, 10.1182/blood-2012-02-408542 · DOI · Paper page
  2. Couronne, 2012, TET2 and DNMT3A mutations in human T-cell lymphoma, N. Engl. J. Med., 366, 95, 10.1056/NEJMc1111708 · DOI · Paper page
  3. Itzykson, 2013, Prognostic score including gene mutations in chronic myelomonocytic leukemia, J. Clin. Oncol., 31, 2428, 10.1200/JCO.2012.47.3314 · DOI
  4. Tefferi, 2009, Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML, Leukemia, 23, 1343, 10.1038/leu.2009.59 · DOI
  5. Grossmann, 2011, Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance, Leukemia, 25, 877, 10.1038/leu.2011.10 · DOI
  6. Quivoron, 2011, TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis, Cancer Cell, 20, 25, 10.1016/j.ccr.2011.06.003 · DOI · Paper page
  7. Chiba, 2017, Dysregulation of TET2 in hematologic malignancies, Int. J. Hematol., 105, 17, 10.1007/s12185-016-2122-z · DOI
  8. Busque, 2012, Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis, Nat. Genet., 44, 1179, 10.1038/ng.2413 · DOI · Paper page
  9. Ko, 2011, Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice, Proc. Natl. Acad. Sci. U. S. A., 108, 14566, 10.1073/pnas.1112317108 · DOI · Paper page
  10. Li, 2011, Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies, Blood, 118, 4509, 10.1182/blood-2010-12-325241 · DOI · Paper page
  11. Zhang, 2016, DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells, Nat. Genet., 48, 1014, 10.1038/ng.3610 · DOI · Paper page
  12. Zang, 2017, Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis, J. Clin. Investig., 127, 2998, 10.1172/JCI92026 · DOI
  13. Muto, 2013, Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders, J. Exp. Med., 210, 2627, 10.1084/jem.20131144 · DOI
  14. Cortes, 2018, RHOA G17V induces T Follicular helper cell specification and promotes lymphomagenesis, Cancer Cell, 33, 259, 10.1016/j.ccell.2018.01.001 · DOI · Paper page
  15. Ganan-Gomez, 2015, Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes, Leukemia, 29, 1458, 10.1038/leu.2015.69 · DOI · Paper page
  16. King, 2011, Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response, Nat. Rev. Immunol., 11, 685, 10.1038/nri3062 · DOI · Paper page
  17. Pietras, 2017, Inflammation: a key regulator of hematopoietic stem cell fate in health and disease, Blood, 130, 1693, 10.1182/blood-2017-06-780882 · DOI · Paper page
  18. Dalamaga, 2002, Risk factors for myelodysplastic syndromes: a case-control study in Greece, Cancer Causes Control, 13, 603
  19. Cortes, 2016, The curious origins of angioimmunoblastic T-cell lymphoma, Curr. Opin. Hematol., 23, 434, 10.1097/MOH.0000000000000261 · DOI
  20. Khayr, 2012, Infections in hematological malignancies, Dis. Mon., 58, 239, 10.1016/j.disamonth.2012.01.001 · DOI
  21. Yan, 2018, Hematopoiesis and the bacterial microbiome, Blood, 132, 559, 10.1182/blood-2018-02-832519 · DOI
  22. Abegunde, 2018, An inflammatory environment containing TNFalpha favors Tet2-mutant clonal hematopoiesis, Exp. Hematol., 59, 60, 10.1016/j.exphem.2017.11.002 · DOI · Paper page
  23. Tsagaratou, 2017, TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells, Nat. Immunol., 18, 45, 10.1038/ni.3630 · DOI · Paper page
  24. Ko, 2013, Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX, Nature, 497, 122, 10.1038/nature12052 · DOI · Paper page

Cited by

See all 38

Metadata

Authors
Zeng, H., He, H., Guo, L., Li, J., Lee, M., Han, W., Guzman, A. G., Zang, S., Zhou, Y., Zhang, X., Goodell, M. A., King, K. Y., Sun, D., & Huang, Y.
Venue
Cancer Letters
Publisher
Elsevier BV
Published
2019-12
Volume
467
Pages
1-8
ISSN
0304-3835
DOI
10.1016/j.canlet.2019.09.013
PMC
PMC6945766
Cited by
38
References
8
Language
en
Licence
Funders
  • National Institutes of Health
  • American Cancer Society
  • Welch Foundation
  • John S. Dunn Foundation
  • Cancer Prevention and Research Institute of Texas

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies. https://app.cochat.ai/papers/10.1016/j.canlet.2019.09.013
The paper
Zeng, H., He, H., Guo, L., Li, J., Lee, M., Han, W., Guzman, A. G., Zang, S., Zhou, Y., Zhang, X., Goodell, M. A., King, K. Y., Sun, D., & Huang, Y. (2019). Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies. Cancer Letters. https://doi.org/10.1016/j.canlet.2019.09.013